Financials
- Market Capitalization 301.65 M
- Employee 75
- Founded 2007
- CEO N/A
- Website www.cartesiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG001J19Q25
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.44
売上高対価格比率
66.95
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3309 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.11 USD | -2.85% | -6.58% | +32.73% | +87.87% | 307.14 M USD | ||
| 3315 | FATE Fate Therapeutics, Inc. - Common Stock | 2.54 USD | -1.17% | +3.25% | +9.01% | +135.19% | 304.34 M USD | ||
| 3325 | TTRX Turn Therapeutics Inc. - Common Stock | 10.11 USD | +4.98% | +4.88% | +32.16% | +1.10% | 301.16 M USD | ||
| 3339 | LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.17 USD | +3.54% | +7.34% | +10.38% | -31.86% | 295.90 M USD |